Digital health provider Ro — which offers online pharmacy services, telehealth and in-home care — has unveiled a new mental health platform for anxiety and depression.

The New York-based startup announced the service — Ro Mind — Tuesday on its Medium page. Ro Mind was created to address the growing demand for mental health care services, particularly in the wake of the pandemic, the company said. Additionally, the service is meant to help break down common mental health barriers such as stigma, access and high care costs.

“This increased demand for mental healthcare highlights the need for patient-centric options that address barriers to care and connect to patients’ primary care and overall health journey,” the company said on its Medium page.

Ro Mind is designed to tackle anxiety and depression, matching users with licensed providers who can diagnose conditions and prescribe medications approved by the U.S. Food and Drug Administration (FDA). Medications are provided through Ro’s nationwide pharmacy network, with prescriptions delivered directly to users’ homes every month. Additionally, the platform contains a variety of educational, pre-recorded videos.

The services will be offered on a cash-pay basis and cost $65 per month.

Prospective Ro Mind users begin by taking an online assessment, which was developed by the company’s medical advisory board. The assessment collects information to determine if applicants are suitable to receive telehealth treatment through Ro Mind, while also notifying providers about risk factors and safety concerns.

Users approved to receive treatment through Ro Mind are notified within 24 hours and are able to schedule a video chat with a behavioral health provider, who will come up with the best individualized treatment plan for the patient. Afterward, Ro Mind coordinates the most appropriate follow up care, which can even include in-person treatment or emergency services. Additionally, patients prescribed medications will be required to complete in video and asynchronous check-ins with Ro Mind.

Ro Mind will initially concentrate on treating users who are dealing with generalized anxiety disorder (GAD) and major depressive disorder (MDD). In the future, Ro plans to expand the platform to add one-on-one and group therapy, as well as support for other mental health conditions.

“Ro believes high-quality, patient-centric care calls for addressing a patient’s mental as well as physical health,” the company said on Medium. “Offering support for anxiety and depression is an important first step toward helping our patients with both their physical and mental health needs and will help make mental healthcare an ongoing part of a patient’s experience on Ro’s platform.”

Ro — which is also known for brands such as the men’s digital health clinic Roman — uses physicians in all 50 states and has had more than 6 million visits to its site since it was founded in 2017. 

To date, Ro has raised $876.1 million, according to the fundraising tracking site Crunchbase. That includes $500 million in a Series D the company announced in March, following a funding round led by the investment firms FirstMark Capital, General Catalyst Partners and TQ Ventures.